ArticleThe Journal of clinical investigation2018

ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation.

Frank P Vendetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.